Role of neurohormonal modulators in heart failure with relatively preserved systolic function

Heart Fail Clin. 2005 Apr;1(1):77-93. doi: 10.1016/j.hfc.2004.10.003. Epub 2005 Jan 7.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged
  • Aged, 80 and over
  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Diastole / drug effects
  • Drug Evaluation
  • Evidence-Based Medicine / methods
  • Female
  • Heart / drug effects
  • Heart Failure / complications
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy*
  • Heart Failure / metabolism*
  • Heart Failure / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists*
  • Neurotransmitter Agents / metabolism*
  • Prognosis
  • Systole / drug effects
  • Ventricular Dysfunction / drug therapy
  • Ventricular Dysfunction / etiology
  • Ventricular Dysfunction / physiopathology

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Mineralocorticoid Receptor Antagonists
  • Neurotransmitter Agents